DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,496,000 | -46.2% | 74,186 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $2,783,000 | +95.2% | 74,186 | +33.0% | 0.00% | +50.0% |
| Q1 2021 | $1,426,000 | -1.7% | 55,786 | -15.3% | 0.00% | 0.0% |
| Q4 2020 | $1,451,000 | +22.4% | 65,880 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,185,000 | -29.2% | 65,880 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,673,000 | +42.1% | 65,880 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,177,000 | -27.1% | 64,080 | -12.6% | 0.00% | 0.0% |
| Q4 2019 | $1,614,000 | +104.3% | 73,280 | +33.3% | 0.00% | +100.0% |
| Q3 2019 | $790,000 | -6.2% | 54,980 | +2.8% | 0.00% | 0.0% |
| Q2 2019 | $842,000 | +55.4% | 53,480 | +44.6% | 0.00% | 0.0% |
| Q1 2019 | $542,000 | +220.7% | 36,980 | +134.1% | 0.00% | – |
| Q4 2018 | $169,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,813,392 | $67,676,000 | 17.58% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $114,954,000 | 7.53% |
| RTW INVESTMENTS, LP | 7,521,859 | $280,716,000 | 4.24% |
| DAFNA Capital Management LLC | 510,756 | $19,061,000 | 3.99% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,892 | $8,580,000 | 3.83% |
| Parkman Healthcare Partners LLC | 304,686 | $11,371,000 | 2.49% |
| Evolutionary Tree Capital Management, LLC | 141,324 | $5,274,000 | 2.43% |
| Eagle Health Investments LP | 161,125 | $6,013,000 | 2.06% |
| Lombard Odier Asset Management (Switzerland) SA | 636,011 | $23,736,000 | 1.20% |
| Woodline Partners LP | 1,000,325 | $37,332,000 | 0.70% |